Clopidogrel - Kyungdong Pharm
Alternative Names: Inhiplat Tab.Latest Information Update: 23 Dec 2021
At a glance
- Originator Kyungdong Pharm
- Class 2 ring heterocyclic compounds; Antiplatelets; Chlorobenzenes; Esters; Pyridines; Small molecules; Thienopyridines
- Mechanism of Action Platelet ADP receptor antagonists; Platelet aggregation inhibitors; Purinergic P2 receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Acute coronary syndromes; Myocardial infarction; Peripheral arterial disorders; Stroke
Most Recent Events
- 28 Aug 2019 No recent reports of development identified for clinical-Phase-Unknown development in Acute coronary syndromes in South Korea (PO, Tablet)
- 28 Aug 2019 No recent reports of development identified for clinical-Phase-Unknown development in Myocardial-infarction in South Korea (PO, Tablet)
- 28 Aug 2019 No recent reports of development identified for clinical-Phase-Unknown development in Peripheral-arterial-disorders in South Korea (PO, Tablet)